Mr. Kukula (MSc, MBA) has over a decade of business experience in the strategic business development and project/product (services) deliver/management using an advanced decision modeling tools (e.g., DPL 8 Syncopation, Vose ModelRisk, Analytica Lumina) for risk estimation, cost benefit analysis, etc. He is also a seasoned science manager with strong scientific background in building and leading Analytical, Mass Spectrometry (proteomics- & small molecules-based), and Bio-molecular & Human Genomics core centers for the last 12 years. Currently, he is a Bioanalytical Core Director in tissue and cell-characterization Institute. His analytical skills (mass spectrometry based techniques) were acknowledged in many research papers published in Science, Chemical Science, J. Am. Chem. Soc., Angewandte Chemie International Edition, ACS Chem. Biol., and many others. Also, he is a co-author of papers published in e.g. Nature Biology Communications, Analytica Chimica Acta, Antimicrobial Agents and Chemotherapy, and presented posters at American Society for Mass Spectrometry and European Congress of Clinical Microbiology and Infectious Diseases. Mr. Kukula has also many years of sales and marketing experience in the life science field. He finished an Executive MBA program in project management from the Naveen Jindal School of management at University of Texas at Dallas and has completed advanced Executive Education course works in business strategy, business model innovation, market validation and New Product Development (the Cox School of Business at Southern Methodist University, The McCombs School of Business at the University of Texas at Austin). He also earned MSc degree in biotechnology from the University of Wroclaw, Poland. He currently resides at Bedford, New Hampshire.
